Delivery Order SPE2DB24D9803-SPE2DB25FJSJQ
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a $12,168.60 firm fixed-price delivery order by the Defense Logistics Agency on September 5, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This delivery order, with an ultimate completion date of September 8, 2025, represents a discrete purchase under DMS Pharmaceutical Group's substantial single-award Indefinite Delivery Contract with the DLA valued at...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,613.94 by the Defense Logistics Agency on April 21, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mls. This firm fixed-price delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499.999 billion and valid through November 2026. The...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $9,958.88 on August 21, 2025, for HUMIRA (adalimumab) pens containing 40 mg/0.4 mL. The order, with an ultimate completion date of August 22, 2025, was issued by the Defense Logistics Agency under a firm fixed-price contract type with no set-aside designation. Performance of the delivery will take place in Conshohocken, Pennsylvania. This...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $5,273.06 by the Defense Logistics Agency (DLA) on August 26, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL. This firm fixed-price delivery order, with an ultimate completion date of August 27, 2025, was issued without a set-aside designation. The contract represents a single delivery order fulfillment under DMS Pharmaceutical...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at one thousand three hundred five dollars and two cents ($1,305.02) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to support military treatment facilities worldwide. Under this particular order, DMS Pharmaceutical Group will deliver HUMIRA pens containing...
- The Defense Logistics Agency awarded a delivery order valued at $4,056.20 to DMS Pharmaceutical Group Inc. for HUMIRA (CF) Pen 40 mg/0.4 mL on July 15, 2025, with a completion date of July 16, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected under a firm fixed-price contract type with no set-aside designation. The delivery order represents a procurement of the branded immunosuppressant medication used to treat...
- The Defense Logistics Agency awarded a $9,450.05 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 16, 2025, for the supply of HUMIRA (CF) Pen 40 mg/0.4 mL with an ultimate completion date of September 17, 2025. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order with place of performance in Conshohocken, Pennsylvania. This award was made without set-aside designation,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $46,955.19 firm fixed-price delivery order is for the supply of HUMIRA(CF) PEN 40 MG/0.4 MLS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $3,244.96 to DMS Pharmaceutical Group Inc. for the supply of HUMIRA (adalimumab) CF Pen 40 mg/0.4 mL on April 24, 2025, with an ultimate completion date of April 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order will be performed at the company's location in Park Ridge,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $8,972.99 contract is for the delivery of HUMIRA(CF) PEN 40 MG/0.4 MLS, a pharmaceutical product, by March 31, 2025. DMS Pharmaceutical Group Inc. is a key supplier of a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense (DoD), including branded and generic...
- SPE2DB24D9803Indefinite Delivery Contract
- SPE2DB24D9803-SPE2DB25FJSJQDelivery Order
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency for HUMIRA (CF) Pen 40 mg/0.4 mls, valued at $5,315.34. The contract was awarded on August 6, 2025, with an ultimate completion date of August 7, 2025, and utilizes firm fixed-price pricing with no set-aside designation. This delivery order represents pharmaceutical supply to support Department of Defense healthcare operations, leveraging DMS Pharmaceutical Group's established role as a critical supplier within the federal pharmaceutical supply chain. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The IDC enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables supporting military health facilities nationwide. DMS Pharmaceutical Group has consistently secured federal pharmaceutical contracts through its woman-owned small business status, establishing itself as a key distributor of specialty medications and medical supplies to the Department of Defense healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.3k | 8/6/25 |